GECAMed, First Luxembourgish Software to Obtain IHE Conformity

GECAMedGECAMed, the medical office management software, developed by the Luxembourg Institute of Science and Technology (LIST) and widely used by Luxembourgish healthcare professionals, has successfully passed IHE profile conformance testing. The interoperability of GECAMed with other solutions available for professionals in the healthcare sector is therefore clearly demonstrated, a first for a Luxembourgish product and moreover for an open source solution.

At the end of April 2015, researchers from the Luxembourg Institute of Science and Technology (LIST) participated in the IHE-Europe Connectathon, an annual connectivity test marathon organised in Luxembourg by IHE-Europe in partnership with the national eSanté Agency. IHE-Europe is the European section of Integrating the Healthcare Enterprise (IHE), an international initiative bringing together professionals from the healthcare and industry sectors, including LIST, to improve information exchange between software systems in this field. The IHE initiative defines integration profiles in order to achieve a high interoperability rate between the systems available to healthcare professionals. The validity of their implementation is tested every year in the context of the Connectathon, where industry professionals meet and connect their applications by using the IHE profiles for designing virtual hospital information systems within a variety of fields, including radiology, cardiology, patient-devices, IT infrastructure, etc.

For the latter, LIST submitted its GECAMed medical office management software for an intensive week of conformance testing, which it successfully passed. GECAMed has thus become not only the first system in Luxembourg to be certified but also the first open-source medical office management system to pass this test with flying colours. This event marks real recognition for the software, since the proven IHE conformity certifies that GECAMed meets all of the strict interoperability criteria regarding security and data sharing at a high international standard.

Towards the integration of GECAMed in the national eHealth platform
GECAMed is a secure open source platform developed by LIST researchers in partnership with doctors in order to manage and use medical data. First launched in 2005 with the support of the Ministry of Health, it has since been constantly adapted and improved in order to meet the needs of professionals in the healthcare sector.

Researchers are currently working towards its technical integration into the national eHealth platform as part of the GECAMed eSanté project co-funded by the eHealth Agency and IDO IN. They therefore designed a new version which integrates patient data from shared medical records (Dossier de Soins Partagé - DSP) with GECAMed data in a user-friendly and transparent way, while complying with the data security and protection guidelines established by the eHealth Agency. Thanks to developments achieved within this project, healthcare professionals will no longer be forced to use the web interface of the eHealth platform. They will have direct access to all documents from their own patient record into which they will also be able to directly integrate documents from the DSP. Local documents and documents from the eHealth platform will therefore be able to be managed very quickly and easily with GECAMed.

For further information, please visit:
http://www.gecamed.lu

About Luxembourg Institute of Science and Technology (LIST)
The Luxembourg Institute of Science and Technology (LIST) is an RTO (Research and Technology Organisation) active in the fields of materials, environment, and IT. Our mission is twofold:

  • contributing to Luxembourg's reputation through our participation in several targeted research areas among the best RTOs,
  • significantly participating in the country's socio-economic development.

To this end, we participate in several national and European competitive research programmes. We disseminate our results through scientific publications in internationally renowned journals, results that we protect by filing patents and that we transfer to key players in the private or public sector.

Thanks to our activities in applied research and technology transfer, we support companies in their innovation projects. The objective is to enable them to enhance their competitiveness in regional, national, and international markets.

Furthermore, we also contribute to the setting up of new companies in Luxembourg through the development of innovative technology and expertise.

Lastly, we offer our scientific support to national policy making in our research areas in order to forecast and support societal changes.

Most Popular Now

Researchers Invent AI Model to Design Ne…

Researchers at McMaster University and Stanford University have invented a new generative artificial intelligence (AI) model which can design billions of new antibiotic molecules that are inexpensive and easy to...

Alcidion and Novari Health Forge Strateg…

Alcidion Group Limited, a leading provider of FHIR-native patient flow solutions for healthcare, and Novari Health, a market leader in waitlist management and referral management technologies, have joined forces to...

Greater Manchester Reaches New Milestone…

Radiologists and radiographers at Northern Care Alliance NHS Foundation Trust have become the first in Greater Manchester to use the Sectra picture archiving and communication system (PACS) to report on...

Powerful New AI can Predict People'…

A powerful new tool in artificial intelligence is able to predict whether someone is willing to be vaccinated against COVID-19. The predictive system uses a small set of data from demographics...

ChatGPT can Produce Medical Record Notes…

The AI model ChatGPT can write administrative medical notes up to ten times faster than doctors without compromising quality. This is according to a new study conducted by researchers at...

Can Language Models Read the Genome? Thi…

The same class of artificial intelligence that made headlines coding software and passing the bar exam has learned to read a different kind of text - the genetic code. That code...

Advancing Drug Discovery with AI: Introd…

A transformative study published in Health Data Science, a Science Partner Journal, introduces a groundbreaking end-to-end deep learning framework, known as Knowledge-Empowered Drug Discovery (KEDD), aimed at revolutionizing the field...

Study Shows Human Medical Professionals …

When looking for medical information, people can use web search engines or large language models (LLMs) like ChatGPT-4 or Google Bard. However, these artificial intelligence (AI) tools have their limitations...

Wanted: Young Talents. DMEA Sparks Bring…

9 - 11 April 2024, Berlin, Germany. The digital health industry urgently needs skilled workers, which is why DMEA sparks focuses on careers, jobs and supporting young people. Against the backdrop of...

Shared Digital NHS Prescribing Record co…

Implementing a single shared digital prescribing record across the NHS in England could avoid nearly 1 million drug errors every year, stopping up to 16,000 fewer patients from being harmed...

Bayer and Google Cloud to Accelerate Dev…

Bayer and Google Cloud announced a collaboration on the development of artificial intelligence (AI) solutions to support radiologists and ultimately better serve patients. As part of the collaboration, Bayer will...

Ask Chat GPT about Your Radiation Oncolo…

Cancer patients about to undergo radiation oncology treatment have lots of questions. Could ChatGPT be the best way to get answers? A new Northwestern Medicine study tested a specially designed ChatGPT...